Navigation Links
Soligenix Demonstrates Positive Proof of Concept with its Proprietary Vaccine Thermostabilization Technology
Date:2/6/2012

PRINCETON, N.J., Feb. 6, 2012 /PRNewswire/ -- Soligenix, Inc. (OTCBB: SNGXD) (Soligenix or the Company), a development stage biopharmaceutical company, announced today results from preclinical studies of its proprietary vaccine thermostabilization technology indicating that Soligenix is able to produce stable vaccine formulations using adjuvants, protein immunogens, and other components that ordinarily would not withstand long temperature variations exceeding customary refrigerated storage conditions.

These studies were conducted with Soligenix's aluminum-adjuvanted ricin toxin vaccine, RiVax™, made under precise lyophilization conditions using excipients that aid in maintaining native protein structure of the ricin A chain, the immunogenic compound of the vaccine. When RiVax™ was kept at 40 degrees C for over one month, all of the animals vaccinated with the lyophilized RiVax™ vaccine developed potent and high titer neutralizing antibodies. In contrast, animals that were vaccinated with the liquid RiVax™ vaccine kept at 40 degrees C did not develop neutralizing antibodies and were not protected against ricin exposure. The ricin A chain is extremely sensitive to temperature and rapidly loses the ability to induce neutralizing antibodies when exposed to temperatures higher than 8 degrees C.

These studies were performed by Theodore W. Randolph, PhD, Professor of Pharmaceutical Biotechnology at the University of Colorado Boulder and John Carpenter, PhD, Professor of Pharmaceutical Biotechnology at the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of Colorado Anschutz Medical Campus. Dr. Randolph stated, "Early indications from the ongoing stability evaluation of the ricin vaccine stored at elevated temperatures are very encouraging for a protein immunogen that is otherwise so inherently unstable."

"We are very excited about these results as the achievement of extended stability under elevated t
'/>"/>

SOURCE Soligenix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Soligenix Announces Publication of Positive Stability Results with RiVax(TM), its Vaccine Against Ricin Toxin
2. Soligenix Announces Publication of Positive Pre-Clinical Results with RiVax(TM), Its Vaccine Against Ricin Toxin
3. Soligenix Announces Initiation of a Phase 1/2 Clinical Trial of SGX201 for the Prevention of Acute Radiation Enteritis
4. Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines
5. Soligenix Announces Issuance of Hong Kong Patent for its LPM(TM) Oral Drug Delivery Technology
6. Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax™ Administration
7. Soligenix to Present at the OneMedForum Conference on Wednesday, June 30 at 2PM EDT
8. Soligenix Announces Award of $1.2 Million FDA Orphan Products Development Grant
9. Soligenix to Present at the Rodman & Renshaw Healthcare Conference on September 15, 2010 at 10AM EDT
10. Soligenix Announces Preliminary Results of its Phase 2 Clinical Trial of orBec® in the Prevention of Acute GVHD
11. Soligenix Announces Positive Preliminary Results of SGX202 in Radiation Injury
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2014)... LOS ALTOS, Calif. , Aug. 18, 2014 ... company developing therapeutics to treat infectious diseases, has ... GBV006, for the treatment of the current Ebola ... approval for the use of GBV006, a combination ... through an established compassionate use regulatory pathway.  The ...
(Date:8/18/2014)... 2014 Reportlinker.com announces that a new ... Global Operating Room Equipment Market ... About Operating Room Equipment ... a sterile environment in a healthcare facility used ... technically advanced equipment, which ensures patient care and ...
(Date:8/18/2014)... NEW YORK , Aug. 18, 2014 /PRNewswire/ ... report is available in its catalogue: ... to 2020 http://www.reportlinker.com/p02280986/Russia-Bariatric-Surgery-Devices-Market-Outlook-to-2020.html ... to 2020 Summary ... Outlook to 2020", provides key market data on ...
Breaking Medicine Technology:Globavir Seeking Approval and Launch of Novel Ebola Treatment Before Year End 2Globavir Seeking Approval and Launch of Novel Ebola Treatment Before Year End 3Globavir Seeking Approval and Launch of Novel Ebola Treatment Before Year End 4Global Operating Room Equipment Market 2014-2018 2Global Operating Room Equipment Market 2014-2018 3Global Operating Room Equipment Market 2014-2018 4Global Operating Room Equipment Market 2014-2018 5Global Operating Room Equipment Market 2014-2018 6Russia Bariatric Surgery Devices Market Outlook to 2020 2Russia Bariatric Surgery Devices Market Outlook to 2020 3Russia Bariatric Surgery Devices Market Outlook to 2020 4Russia Bariatric Surgery Devices Market Outlook to 2020 5
... Nash Corporation (Nasdaq: KNSY ), today announced that it ... Euronext: DSM KON), under which DSM has agreed to acquire all ... offer, followed by a merger with a subsidiary of DSM, for ... pleased to have entered into the merger agreement with DSM, as ...
... May 2, 2012 Synteract , Inc., a ... biopharmaceutical company developing new therapies to combat the growing ... annual Great Strides fundraising walk to benefit ... Synteract and Rempex (on behalf of Aptalis Pharma) are ...
Cached Medicine Technology:Kensey Nash Agrees to Be Acquired by DSM for $38.50 per Share in Cash 2Kensey Nash Agrees to Be Acquired by DSM for $38.50 per Share in Cash 3Kensey Nash Agrees to Be Acquired by DSM for $38.50 per Share in Cash 4Kensey Nash Agrees to Be Acquired by DSM for $38.50 per Share in Cash 5Kensey Nash Agrees to Be Acquired by DSM for $38.50 per Share in Cash 6Synteract and Rempex Partner in "Great Strides" Walk to Support Cystic Fibrosis Cure 2
(Date:8/20/2014)... (PRWEB) August 20, 2014 AttorneyOne.com, a recognized ... latest information from the FDA on Sodium Chloride IV ... that one lot of Sodium Chloride IV 0.9%, USP 1000 ... to the presence of particulate matter. Sodium Chloride Injection, USP ... as a priming solution in hemodialysis procedures. , ...
(Date:8/20/2014)... At this moment, Ebola is causing horrific, ... the root cause of the virus and other problems Africans ... nonprofit organization Books For Africa to provide copies of his ... Live the Life of Their Dreams, to those who could ... with the tools they need to make the leap to ...
(Date:8/20/2014)... Over 31 million Americans suffer from low back ... pain is the single leading cause of disability worldwide, and ... Americans spend at least $50 billion each year trying to ... pain are not due to organic conditions such as arthritis; ... a busy accountant, had little time for physical activity or ...
(Date:8/19/2014)... 2014 BambooIndustry.com, a well-known bamboo product manufacturer ... deckings recently. The company is excited to reveal the ... special offer for all clients. Now, every customer can get ... will last until August 30. , The company’s deckings ... the world for supreme durability. They are perfect for a ...
(Date:8/19/2014)... What gives skin an edge and is that ... and nourish it while lightly exfoliating? The Collagen ... raves about how their skin feels and looks after using ... Beauty®. "The ingredients are very rich and spa-quality." , The ... over cleansed skin of the face and neck, and let ...
Breaking Medicine News(10 mins):Health News:Sodium Chloride IV 0.9% by Baxter Recalled: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Ebola, Poverty, and a Partnership for Africa—How Everyone Can Help 2Health News:Ebola, Poverty, and a Partnership for Africa—How Everyone Can Help 3Health News:Physical Therapists Learn to Relieve Low Back Pain 2Health News:Promotional Bamboo Deckings from Well-known Online Supplier BambooIndustry.com 2Health News:That "Something Special" to Improve Skin Takes Only 10 Minutes Per Week; on Sale at Sublime Beauty® 2
... combination of services plus technology helps physicians improve ... efficiency and reduce their administrative burden., ... provider of health care BPO services, today announced ... ) CBayPraxis is a revolutionary electronic patient ...
... toll on the heart, kidney and liver as well ... a high risk of early death. This sobering ... whether longevity has improved for RA patients over the ... the general population. Are earlier diagnosis, breakthrough drugs, ...
... "Kids and the Growing Allergy Threat" (p. 42). Senior ... allergies in adults,and children. Today at least 11 million ... 1997 and 2002 in children,under 5. Allergists say they,re ... not just to 1950s staples such as milk and,wheat-but ...
... Oregon Health & Science University Cancer Institute researchers ... stomachs rather than their backs is a better method ... therapies, being able to reproduce ,the positioning of the ... , It was a surprising finding, according to according ...
... ANGELES, Oct. 28 Results from a University of ... head and neck cancer can be uniformly delivered in ... cancer centers through a centralized planning and treatment process. ... meeting of the American Society for Therapeutic Radiology and ...
... La., Oct. 28 Tangiers International LLC,a global ... forces with American International Group, Inc (AIG), to ... for injured,contractors covered under the Defense Base Act. ... is excited about,this opportunity to expand with AIG, ...
Cached Medicine News:Health News:CBaySystems Introduces CBayPraxis - A Breakthrough Solution Focused on Physician Practice Efficiency 2Health News:CBaySystems Introduces CBayPraxis - A Breakthrough Solution Focused on Physician Practice Efficiency 3Health News:CBaySystems Introduces CBayPraxis - A Breakthrough Solution Focused on Physician Practice Efficiency 4Health News:The widening mortality gap between people with rheumatoid arthritis and the general population 2Health News:The widening mortality gap between people with rheumatoid arthritis and the general population 3Health News:NEWSWEEK: Media Lead Sheet/November 5, 2007 Issue (on newsstands Monday, October 29). 2Health News:NEWSWEEK: Media Lead Sheet/November 5, 2007 Issue (on newsstands Monday, October 29). 3Health News:NEWSWEEK: Media Lead Sheet/November 5, 2007 Issue (on newsstands Monday, October 29). 4Health News:Positioning pelvic cancer patients on stomachs for radiation yields better results 2Health News:Integrated approach to IMRT provides quality care for head and neck cancer patients 2Health News:Tangiers International Announces New Medical Support Services in Iraq for American International Group (AIG) 2
... The GoodKnight 420 CPAP System is the ... (CPAP) device on the market. It is ... preserve their lifestyles while complying with therapy. ... 600 sessions of date/time usage data. It ...
Micro-hematocrit tubes available in multiple sizes and additives for a wide range of capillary blood collection....
... VH IVUS technology uses advanced spectral ... of ultrasound images and provide detailed ... patient's atherosclerotic plaques. The colorized VH ... fibrous, fibro-fatty, dense calcium, and necrotic ...
... With the GE Innova 2100IQ: See the ... legs. Place interventional devices. Its all enabled ... panel that helps deliver excellent image quality ... Innova family systems installed worldwide, more physicians ...
Medicine Products: